M. Vilien

Zealand University Hospital — Denmark

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index2.5kcitations52works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(16), Microscopic Colitis(12), Helicobacter pylori-related gastroenterology studies(7), Bladder and Urothelial Cancer Treatments(6), Immunotherapy and Immune Responses(6)

Publications52 total

Cross-species high-resolution transcriptome profiling suggests biomarkers and therapeutic targets for ulcerative colitis
Frontiers in Molecular Biosciences·2023· 5 citedOpen Access
Transcriptome profiling of ulcerative colitis mouse model suggests biomarkers and therapeutic targets for human colitis
2020· 2 citedOpen Access
GLP-1 Induces Barrier Protective Expression in Brunnerʼs Glands and Regulates Colonic Inflammation
Inflammatory Bowel Diseases·2016· 97 cited
Transcriptomic landscape of lncRNAs in inflammatory bowel disease
Genome Medicine·2015· 179 citedOpen Access
Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid-Refractory Ulcerative Colitis: A Retrospective Observational Study
Inflammatory Bowel Diseases·2011· 61 cited
Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study
Alimentary Pharmacology & Therapeutics·2010· 179 citedOpen Access
Cyclosporin eller infliximab som rescue terapi vid steroidfraktär ulcerös kolit : en retrospective observationsstudie
2010
Outcome of rescue therapy in steroid-resistant ulcerative colitis : a retrospective study comparing cyclosporine and infliximab
Gut·2008· 1 cited
Colectomy after rescue therapy for intravenous-steroid resistant acute ulcerative colitis : a 3-year follow-up study of the Swedish-Danish infliximab/placebo trial
Gut·2008· 6 cited
A 2-year follow-up of the swedish-danish Infliximab/Placebo trial in steroid resistant acute ulcerative colitis
Gastroenterology·2007· 17 cited
Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study
Gastroenterology·2005· 1.1k citedOpen Access
Şiddetli veya Orta Şiddetli Ülseratif Kolitte Kurtarıcı Tedavi Olarak İnfliximab: Randomize, Placebo-Kontrollü Bir Çalışma
Gastroenterology·2005
Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year
Alimentary Pharmacology & Therapeutics·2004· 76 citedOpen Access
On-Demand Treatment in Patients with Oesophagitis and Reflux Symptoms: Comparison of Lansoprazole and Omeprazole
Scandinavian Journal of Gastroenterology·2002· 50 cited
[Azathioprine treatment of Crohn disease].
PubMed·2000
The Effect of Cisapride in Maintaining Symptomatic Remission in Patients with Gastro-Oesophageal Reflux Disease
Scandinavian Journal of Gastroenterology·1997· 29 cited
[Prevention of duodenal ulcer recurrence with penicillin].
PubMed·1994
Prevention of Duodenal Ulcer Recurrence with Penicillin: A Double-Blind, Placebo-Controlled Trial
Scandinavian Journal of Gastroenterology·1993· 11 cited
Prevention of Duodenal Ulcer Recurrence with Penicillin
Scandinavian Journal of Gastroenterology·1993· 4 cited
Abstract form for the Irish Journal of Medical Science v workshop on gastroduodenal pathology and Helicobacter pylori July 5th — 7th 1992 — Dublin, Ireland
Irish Journal of Medical Science (1971 -)·1992· 3 cited
page 1 of 3Next →

Frequent Co-authors

Erik Hertervig(8), Per Karlén(8), Christer Grännö(8), Hans Verbaan(8), Per M. Hellström(8), Hans Wolf(7), Ingalill Friis–Liby(6), Anders Magnuson(6), Jonas Halfvarson(6), Curt Tysk(6), Finn Rasmussen(6), Anders Gustavsson(5), O Bonnevie(5), Gunnar Järnerot(4), Lars Blomquist(4), Magnus Ström(4), Flemming Pociot(4), L. Blomquist(4), V. Binder(4), Peter A. Krasilnikoff(4)